Findings
========

Persistent infection with high risk HPV is a necessary cause for invasive cervical cancer; studies on HPV type distribution among ICC cases worldwide have shown some geographical variation \[[@B1]\]. Limited data on HPV type distribution among ICC cases from Italy are available to date \[[@B2]\]; this information is useful in view of the availability of type-restricted prophylactic vaccines in the very near future. We retrieved consecutive incident cases of ICC occurred during the years 1997--1999 in Italian women living in the North-East area from the Venetian Tumour Registry files, and selected the cases whose samples had been processed in the Pathology Departments of Padova and Vicenza.

A total of 48 ICC cases were selected; 43 squamous cell cancers (SCC) and 5 adenocarcinomas. Median age at diagnosis was 55 yrs (range 28--89). DNA was extracted from formalin-fixed paraffin-embedded samples by using the QIAamp DNA minikit (Qiagen GmbH, Germany), according to the manufacturer\'s instructions. To verify DNA quality, amplification of a 268 bp fragment of the Beta-globin gene was performed using PC04/GH20 primers. HPV detection was conducted using GP5+/GP6+ general consensus primers (which amplify a fragment of approximately 140--150 bp), as previously described \[[@B3]\], and 0.5 U of AB SuperTaq (AB Analitica, Padova, Italy). HPV types were identified by direct sequencing; PCR products were purified by ExoSAP-IT (USB Corporation, Ohio, USA) and subjected to cycle sequencing by ABI PRISM Big Dye Terminator Cycle Sequencing kit (Applera, Foster City, CA, USA), and sequencing reactions were run on the ABI PRISM 310 Genetic Analyzer (Applied Biosystems). The BLAST server was used to match all sequences available in GenBank \[[@B4]\]. HPV 16 type specific primers H16L1/H16R3 were used to amplify a 323 bp fragment in the E6 gene, as previously described \[[@B5]\], and the fragments subjected to direct sequencing (from both directions) to characterize the isolates; variants were defined by comparison to HPV 16 prototype sequences. HPV 16 and HPV 18 type specific primers amplifying fragments of 98 bp and 118 bp, respectively, were also used, as previously described \[[@B6]\]. Samples resulted negative for HPV DNA or untypable by direct sequencing and type-specific PCRs were further tested by nested PCR and reverse dot blot by using the HPV-HS BIO and HPV Strip Detection kits (AB Analitica, Padova, Italy), according to the manufacturer\'s instructions, which allow the detection of HPV types 6, 11, 34, 40, 43, 44, 53, 54, 61, 69, 70, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66.

Of the 48 cases analyzed, 3 SCC resulted negative for the housekeeping gene and were excluded, and 1 SCC was negative for HPV DNA with all the tests used. The remaining 44 cases (97.8%) were positive for HPV sequences; 39 single infections and 5 (11.4%) double infections, as described in Table [1](#T1){ref-type="table"}. In 8 cases the type could be determined only by nested PCR followed by reverse dot blot, and all the 5 mixed infections were in this group. Overall, the most frequently detected types were HPV 16, 18 and 33 (cumulatively, 37/44, 84.1%). HPV 16 E6 gene could be sequenced in 25 cases; in 6 cases amplification with the E6 type specific primers was negative, and in 1 the amplified fragment could not be successfully sequenced. The E6 pattern corresponded to the prototype in 7 cases, while the T350G mutation was present in 18; as single mutation in 14, with another mutation in 3 (T256C, A257G, A442C, respectively), and with three additional mutations in 1 (T286A, A289G, C335T).

###### 

HPV type distribution in relation to histology among 44 HPV positive invasive cervical cancers.

  HPV types         Histology   
  ----------------- ----------- ---
  HPV 16            26          2
  HPV 16 + HPV 18   3           
  HPV 16 + HPV 31   1           
  HPV 18                        1
  HPV 33            2           2
  HPV 35            1           
  HPV 45            2           
  HPV 52            1           
  HPV 56 + HPV 70   1           
  HPV 58            2           

Overall, 44 out of the 45 valuable ICC Italian cases occurred during 1997--1999 were HPV positive. HPV 16 was detected in 32 cases (72.7%), a result indicating a very high prevalence in Italy, in keeping with other studies \[[@B2],[@B7],[@B8]\]. Indeed, in our region HPV 16 is the most prevalent type also in high grade lesions; 40% of samples cytologically diagnosed as high grade squamous intraepithelial lesions \[[@B9]\], and 65.5% (36/55) of histologically confirmed CIN3/CIS (data not shown). These data are in line with the notion that HPV 16 positive infections are at great risk of clinical progression and need a closer follow-up, as recommended also by other authors \[[@B10]\]. This implies that when searching for HPV sequences in clinical samples, careful attention must be paid to the detection of type 16; in our experience, testing by HPV 16 type-specific PCR in adjunct to consensus primers PCR is very useful to guarantee high sensitivity for this type, since HPV 16 infections can sometimes be missed by consensus primers in cases of mixed infections and/or low viral load. A mixed infection was detected in 5 (11.4%) of our cases; this result is somehow surprising, but mixed infections have been detected in invasive cervical cancers also by other authors \[[@B11]\]. Indeed, different data have been obtained so far on the frequency and the role in cervical neoplasia development of coinfections with multiple HPV types. This can be due to differences in the studied population or in the typing methodology used. In our study the five double infections were all found by nested PCR followed by reverse dot blot, and it is known that reverse hybridization methods are more sensitive than sequencing in detecting multiple genotypes \[[@B12]\].

Sequence analysis of the E6 gene in 25 HPV 16 positive ICC cases showed the presence of the T350G mutation in the great majority (18/25, 72%), in 4 cases also accompanied by other mutations; among the mutations identified, A257G, C335T, T350G, A442C lead to amino acid changes (I52V, H78Y, L83V, E113D, respectively), while C256T, T286A, A289G are silent not leading to amino acid changes \[[@B13],[@B14]\]. Interestingly, the A257G mutation has been firstly described very recently, and occurred in combination with the T350G variant \[[@B14]\], as in our case. Variations in the viral genes leading to amino acid substitutions can alter the biological functions of the encoded proteins or their antigenic properties. Of the naturally occurring HPV 16 viral variants, the T350G (L83V) is the most commonly found among invasive cancers \[[@B15]\], and has been linked to an increased risk for cervical disease progression \[[@B14]\].

HPV 33 was detected in 4 cases, resulting the second most frequent type (together with type 18), a result observed also in The Netherlands \[[@B16]\].

In conclusion, our results suggest that HPV 16 has a very high prevalence among women with invasive cervical cancer living in Italy, implying that a prophylactic vaccine for types 16 and 18 could prevent up to 75% of cancer cases in Italy.
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